what this node claims
AlphaFold metrics / THRB
Model-quality receipt for the fold. It is not biological validation.
vertical proof spine
evidence / risk instrument
53%
low debt pressure
21%
80%structurestrong
pLDDT 80.21
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, candidate, finding, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence band
- confident
- confidence pct
- 80.21
- coverage context
- missing or not linked
- interpretation
- usable fold context with explicit model-confidence limits
- pae context
- missing or not linked
- plddt avg
- 80.21
- sequence length
- 0
AlphaFold metrics visual
Confident backbone model
461 residues / min 19.47 / max 98.81 / source alphafold db
Very high
69.2%
319 residues / >=90
Confident
7.6%
35 residues / 70-89
Low
2.0%
9 residues / 50-69
Very low
21.3%
98 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 461 of 461 residues.
- residues 1-95 / mean 28.28
- residues 254-262 / mean 51.51
- residues 207-209 / mean 64.66
proof debt register
21%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.